The United States Patent and Trademark Office (USPTO) has received a new trademark application (TM99317125) for the mark EVERLIV. This is an intent-to-use application, meaning the applicant intends to use the mark in commerce in the future. The application specifically covers "Medical services; Regenerative medicine services." The filing date for this application was August 3, 2025.

This filing represents the initiation of the trademark registration process for the EVERLIV mark within the specified medical service categories. While this is a notice of a filing and not a rule or enforcement action, entities operating in the regenerative medicine or broader medical services sector should be aware of new marks being registered. There are no immediate compliance actions required for other entities based on this filing, but it may have implications for future branding and market positioning.